BACKGROUND: Involvement of large arteries is well-documented in giant-cell arteritis (GCA), but the risk for cardiovascular events is not well-understood. OBJECTIVE: To evaluate the risks for incident myocardial infarction (MI), cerebrovascular accident (CVA), and peripheral vascular disease (PVD) in individuals with incident GCA in a general population context. DESIGN: Observational cohort study. SETTING: U.K. primary care database. PATIENTS: 3408 patients with incident GCA and 17 027 age- and sex-matched reference participants without baseline cardiovascular disease (MI, CVA, or PVD). MEASUREMENTS: Diagnoses of GCA, outcomes, and cardiovascular risk factors were identified from electronic medical records. One combined and 3 separate cohort analyses were conducted for the outcomes of MI, CVA, and PVD. The association of GCA with study outcomes is expressed with hazard ratios (HRs) with 95% CIs after adjustment for potential cardiovascular risk factors. RESULTS: Among 3408 patients with GCA (73% female; mean age, 73 years), the incidence rates of MI, CVA, and PVD were 10.0, 8.0, and 4.2 events per 1000 person-years, respectively, versus 4.9, 6.3, and 2.0 events per 1000 person-years, respectively, among reference participants. The HRs were 1.70 (95% CI, 1.51 to 1.91) for the combined outcome, 2.06 (CI, 1.72 to 2.46) for MI, 1.28 (CI, 1.06 to 1.54) for CVA, and 2.13 (CI, 1.61 to 2.81) for PVD. The HRs were more pronounced in the first month after GCA diagnosis (combined HR, 4.92 [CI, 2.59 to 9.34]; HR for MI, 11.89 [CI, 2.40 to 59.00]; HR for CVA, 3.93 [CI, 1.76 to 8.79]; HR for PVD, 3.86 [CI, 0.78 to 19.17]). LIMITATION: Information on temporal arterial biopsies was not available, and there was a substantial amount of missing data on cardiovascular risk factors. CONCLUSION: Giant-cell arteritis is associated with increased risks for MI, CVA, and PVD. PRIMARY FUNDING SOURCE: National Institute of Arthritis and Musculoskeletal and Skin Diseases.
BACKGROUND: Involvement of large arteries is well-documented in giant-cell arteritis (GCA), but the risk for cardiovascular events is not well-understood. OBJECTIVE: To evaluate the risks for incident myocardial infarction (MI), cerebrovascular accident (CVA), and peripheral vascular disease (PVD) in individuals with incident GCA in a general population context. DESIGN: Observational cohort study. SETTING: U.K. primary care database. PATIENTS: 3408 patients with incident GCA and 17 027 age- and sex-matched reference participants without baseline cardiovascular disease (MI, CVA, or PVD). MEASUREMENTS: Diagnoses of GCA, outcomes, and cardiovascular risk factors were identified from electronic medical records. One combined and 3 separate cohort analyses were conducted for the outcomes of MI, CVA, and PVD. The association of GCA with study outcomes is expressed with hazard ratios (HRs) with 95% CIs after adjustment for potential cardiovascular risk factors. RESULTS: Among 3408 patients with GCA (73% female; mean age, 73 years), the incidence rates of MI, CVA, and PVD were 10.0, 8.0, and 4.2 events per 1000 person-years, respectively, versus 4.9, 6.3, and 2.0 events per 1000 person-years, respectively, among reference participants. The HRs were 1.70 (95% CI, 1.51 to 1.91) for the combined outcome, 2.06 (CI, 1.72 to 2.46) for MI, 1.28 (CI, 1.06 to 1.54) for CVA, and 2.13 (CI, 1.61 to 2.81) for PVD. The HRs were more pronounced in the first month after GCA diagnosis (combined HR, 4.92 [CI, 2.59 to 9.34]; HR for MI, 11.89 [CI, 2.40 to 59.00]; HR for CVA, 3.93 [CI, 1.76 to 8.79]; HR for PVD, 3.86 [CI, 0.78 to 19.17]). LIMITATION: Information on temporal arterial biopsies was not available, and there was a substantial amount of missing data on cardiovascular risk factors. CONCLUSION:Giant-cell arteritis is associated with increased risks for MI, CVA, and PVD. PRIMARY FUNDING SOURCE: National Institute of Arthritis and Musculoskeletal and Skin Diseases.
Authors: G G Hunder; D A Bloch; B A Michel; M B Stevens; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie Journal: Arthritis Rheum Date: 1990-08
Authors: Ravi Suppiah; Andrew Judge; Rajbir Batra; Oliver Flossmann; Lorraine Harper; Peter Höglund; M Kassim Javaid; David Jayne; Chetan Mukhtyar; Kerstin Westman; John C Davis; Gary S Hoffman; W Joseph McCune; Peter A Merkel; E William St Clair; Philip Seo; Robert Spiera; John H Stone; Raashid Luqmani Journal: Arthritis Care Res (Hoboken) Date: 2011-04 Impact factor: 4.794
Authors: Gary S Hoffman; Maria C Cid; David B Hellmann; Loic Guillevin; John H Stone; John Schousboe; Pascal Cohen; Leonard H Calabrese; Howard Dickler; Peter A Merkel; Paul Fortin; John A Flynn; Geri A Locker; Kirk A Easley; Eric Schned; Gene G Hunder; Michael C Sneller; Carol Tuggle; Howard Swanson; J Hernández-Rodríguez; Alfons Lopez-Soto; Debora Bork; Diane B Hoffman; Kenneth Kalunian; David Klashman; William S Wilke; Raymond J Scheetz; Brian F Mandell; Barri J Fessler; Gregory Kosmorsky; Richard Prayson; Raashid A Luqmani; George Nuki; Euan McRorie; Yvonne Sherrer; Shawn Baca; Bridgit Walsh; Diane Ferland; Martin Soubrier; Hyon K Choi; Wolfgang Gross; Allen M Segal; Charles Ludivico; Xavier Puechal Journal: Arthritis Rheum Date: 2002-05
Authors: Max Yates; Robert Luben; Shabina Hayat; Sarah L Mackie; Richard A Watts; Kay-Tee Khaw; Nick J Wareham; Alex J MacGregor Journal: Rheumatology (Oxford) Date: 2020-02-01 Impact factor: 7.580
Authors: Clement John Michet; Sara J Achenbach; Cynthia S Crowson; Eric L Matteson Journal: Semin Arthritis Rheum Date: 2015-03-03 Impact factor: 5.532
Authors: Shubhasree Banerjee; Mohammadhadi Bagheri; Veit Sandfort; Mark A Ahlman; Ashkan A Malayeri; David A Bluemke; Jianhua Yao; Peter C Grayson Journal: Semin Arthritis Rheum Date: 2018-09-17 Impact factor: 5.532
Authors: Lillian Armellin; Anthony Michael Sammel; Ben Ng; Kiran Sarathy; John Lambros; Taraneh Amir-Nezami; Shannon Dean Thomas; John Highton; Arvin Damodaran Journal: J Cardiol Cases Date: 2017-06-27